Search Results

You are looking at 1 - 3 of 3 items for

  • Author: Jian-Qin Liu x
Clear All Modify Search
Open access

Sou Nobukawa, Haruhiko Nishimura, Teruya Yamanishi and Jian-Qin Liu

Abstract

Several hybrid neuron models, which combine continuous spike-generation mechanisms and discontinuous resetting process after spiking, have been proposed as a simple transition scheme for membrane potential between spike and hyperpolarization. As one of the hybrid spiking neuron models, Izhikevich neuron model can reproduce major spike patterns observed in the cerebral cortex only by tuning a few parameters and also exhibit chaotic states in specific conditions. However, there are a few studies concerning the chaotic states over a large range of parameters due to the difficulty of dealing with the state dependent jump on the resetting process in this model. In this study, we examine the dependence of the system behavior on the resetting parameters by using Lyapunov exponent with saltation matrix and Poincaré section methods, and classify the routes to chaos.

Open access

Wen Xie, Hong Zhao, Yu Chen, Qin Zhang, Wei Lu, Wei Liu, Ai-rong Hu, Han-wei Li, Ping Feng, Ming-sheng Chen, Cun-jin Mei, Xiao-lin Guo, Xiao-hu Zhao, Jiang-bin Wang, Zheng-qin Fan, Jian-he Gan, Qing Xie and Jun Cheng

Abstract

Obejective Ademetionine 1,4-butanedisulfonate [S-adenosyl-L-methionine (SAMe)/Transmetil®, Abbott] has been available in China for more than 15 years, and it has been shown to reduce serum bilirubin and transaminase levels in viral hepatitis (VH) patients. However, no large-scale studies have focused on the impact of SAMe treatment regimen on reducing the serum total bilirubin (TBil) in VH patients with intrahepatic cholestasis (IHC). The primary purpose of this study was to evaluate the effectiveness of intravenous SAMe (Transmetil®) treatment in reducing the serum TBil by 50%.

Methods This retrospective, multi-center, cross-sectional medical record review involved patients aged ≥18 years. Records of 1 280 hospitalized VH patients at 16 sites diagnosed with IHC who had received intravenous SAMe 1 000 mg or 2 000 mg q.d. for at least 7 days from January 1, 2006 to June 30, 2009, were screened and 905 records were randomly selected.

Results The safety set (SS) included 834 patients and the full analysis set 826 patients. TBil levels after 14 days injection treatment were available for 763 patients. TBil decreased ≥ 50% versus baseline after 14 days treatment in 288 (37.7%) patients (95% CI 34.3%, 41.2%). Twenty-nine non-serious adverse events (non-SAEs) were reported in 19 (2.3%) patients, and 29 SAEs were reported in 10 patients (1.2%). All adverse events (AEs) were considered unrelated to the study drug.

Conclusions This retrospective study shows that intravenous SAMe administration in VH patients with IHC is associated with significant reduction of TBil levels in more than 30% of patients 14 days after treatment initiation.

Open access

Guo-liang Zhang, Jian-bo Ding, Shuang-jie Li, Xi Zhang, Yi Xu, Hua-sheng Yang, Dan Wei, Qin Li, Qing-sheng Shi, Qing-xiong Zhu, Tong Yang, Zi-qiang Zhuo, Yi-mei Tian, Hao-jie Zheng, Liu-ping Tang, Xin-ying Zou, Tao Wen and Xiu-hui Li

Objective To evaluate the efficacy and safety of traditional Chinese medicine (TCM) combined with Western medicine in the treatment of patients with common hand, foot and mouth disease (HFMD) by conducting a prospective, controlled, and randomized trial.

Methods A total of 452 patients with common HFMD were randomly assigned to receive Western medicine alone (n = 220) or combined with TCM (Reduning or Xiyanping injections) (n = 232). The primary outcome was the incidence rate of rash/herpes disappearance within 5 days, while secondary outcomes included the incidence rate for fever, cough, lethargy, agitation, and vomiting clearance within 5 days.

Results The rash/herpes disappearance rate was 45.5% (100/220) in Western medicine therapy group, and 67.2% (156/232) in TCM and Western medicine combined therapy group, with significant difference (P < 0.001). Moreover, TCM remarkably increased the incidence rate of secondary disappearance, which was 56.4% in Western medicine therapy group and 71.4% in TCM and Western medicine combined therapy group (P = 0.001). No drug-related adverse events were observed.

Conclusions It’s suggested that the integrative TCM and Western medicine therapy achieved a better therapeutic efficacy. TCM may become an important complementary therapy on relieving the symptoms of HFMD.